CRS News and Press, Carpenter Technology Corporation From 07/30/21

The following slide deck was published by Carpenter Technology Corporation in conjunction with their 2021 Q4 earnings call. For further details see: Carpenter Technology Corporation 2021 Q4 - Results - Earnings Call Presentation

Image source: The Motley Fool. Carpenter Technology Corp (NYSE: CRS) Q4 2021 Earnings Call Jul 29, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: Carpenter Technology Corp (CRS) Q4 2021 Earnings Call Transcript

Carpenter Technology (NYSE:CRS): FQ4 Non-GAAP EPS of -$0.28 beats by $0.22; GAAP EPS of -$1.18 misses by $0.41. Revenue of $421.6M (-3.6% Y/Y) beats by $34.6M. CEO comment: “Looking ahead, our focus is centered on capitalizing on emerging opportunities across our end-use markets as con...

PHILADELPHIA, July 29, 2021 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal fourth quarter and year ended June 30, 2021. For the quarter, the Company reported a net loss of $57.1 million, or $1.1...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...

Bristol Myers Squibb (BMY) announces that the EMA's Committee for Medicinal Products for Human Use ((CHMP)) has recommended granting Conditional Marketing Authorization for Abecma (idecabtagene vicleucel; ide-cel), the company’s BCMA-directed chimeric antigen receptor ((CAR)) T cell im...

PHILADELPHIA, June 14, 2021 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) today announced that Dr. David Graf has been appointed to lead Carpenter Technology’s Specialty Alloys Operations (SAO) business segment as Vice President and Group President – SA...

Precision BioSciences (DTIL) announces progress on two strategies designed to optimize the durability of allogeneic CAR T therapy in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma ((NHL)).The Company reported updated interim results from its Phase 1/2a study of PBCAR0191, an inv...